dc.contributor.author | M, Odoki | |
dc.contributor.author | J, Bazira | |
dc.contributor.author | ML, Moazam | |
dc.contributor.author | E, Agwu | |
dc.date.accessioned | 2022-05-26T09:46:41Z | |
dc.date.available | 2022-05-26T09:46:41Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Odoki, M., Bazira, J., Moazam, M. L., & Agwu, E. (2015). Health-point survey of bacteria urinary tract infections among suspected diabetic patients attending clinics in Bushenyi district of Uganda. Spec Bact Pathog J. 2015; 1 (1): 01, 9, 11-20. | en_US |
dc.identifier.uri | http://ir.must.ac.ug/xmlui/handle/123456789/2060 | |
dc.description.abstract | Background: Although Urinary tract infections (UTI) and diabetes are individual public health pandemic, their comorbidities remain a global health dilemma. Regional surveillance holds the key to effective intervention.
Objectives: To evaluate the prevalence and antibacterial resistance pattern of bacteria etiological agents of UTI among diabetic patients in the Bushenyi district of Uganda.
Methods: In this cross-sectional study, 418 midstream urines from consenting 331 diabetics (230 females and 101 males) and 87 non-diabetic (60 females and 27 males) individuals were collected aseptically and processed using standard microbiological methods. Data generated were tested for statistical significance and scientific relevance.
Results: Bacteria UTI was 31.1% prevalent in diabetic and 11.4% in non-diabetics. Diabetic patients yielded: 13.6%, Staphylococcus species, 8.8% E.coli, and 8.6% Klebsiella species. Klebsiella species showed 100% resistance to Erythromycin, 71.4% to Cotrimoxazole, and 92.9% to Ampicillin. Bacteria from diabetic patients remained sensitive to Nitrofurantoin, Ciprofloxacin, Ceftazidime, and Ceftriaxone. Extended Spectrum β-Lactamases were detected in 3.5% of Klebsiella species. Age and sex significantly (p<0.05) influenced diabetic UTI prevalence.
Conclusion: Diabetes significantly (p<0.05) influenced the observed (27%) UTI distribution. Resistance to Ampicillin and Cotrimoxazole may affect their use in UTI management. Antibacterial misuse is highly discouraged and Nitrofurantoin remains urinary antiseptic. | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | Special Bacteria Pathogens Journal (SBPJ) | en_US |
dc.subject | Diabetic patients | en_US |
dc.subject | Bacteria UTI | en_US |
dc.subject | Bushenyi | en_US |
dc.subject | Uganda | en_US |
dc.title | Health-point survey of bacteria urinary tract infections among suspected diabetic patients attending clinics in Bushenyi, Uganda | en_US |
dc.type | Article | en_US |